BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6177885)

  • 1. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
    Nakashima T
    Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
    [No Abstract]   [Full Text] [Related]  

  • 2. The acclumulation of 35 S-antithyroid drugs by the thyroid gland.
    Marchant B; Alexander WD; Lazarus JH; Lees J; Clark DH
    J Clin Endocrinol Metab; 1972 May; 34(5):847-51. PubMed ID: 4111035
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of antithyroid drugs.
    Benker G; Reinwein D
    Klin Wochenschr; 1982 Jun; 60(11):531-9. PubMed ID: 6180218
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism of 35S-labelled antithyroid drugs in thyrotoxic, adenomatous, neoplastic and normal human thyroid.
    Lazarus JH; Marchant B; Alexander WD; Clark DH
    Clin Sci; 1973 Jun; 44(6):24P. PubMed ID: 4123392
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of antithyroid drugs in maternal milk].
    Johansen K; Kampmann JP; Hansen JM; Andersen AN; Helweg J
    Ugeskr Laeger; 1982 May; 144(22):1635-7. PubMed ID: 6182662
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithyroid drugs interact with renal medullary prostaglandin H synthase.
    Zelman SJ; Rapp NS; Zenser TV; Mattammal MB; Davis BB
    J Lab Clin Med; 1984 Aug; 104(2):185-92. PubMed ID: 6205111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
    Nakashima T; Taurog A; Riesco G
    Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic S-methylation of 6-n-propyl-2-thiouracil and other antithyroid drugs.
    Lindsay RH; Hulsey BS; Aboul-Enein HY
    Biochem Pharmacol; 1975 Feb; 24(4):463-8. PubMed ID: 46147
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of 35S-labelled antithyroid drugs in man.
    Alexander WD; Evans V; MacAulay A; Gallagher TF; Londono J
    Br Med J; 1969 May; 2(5652):290-1. PubMed ID: 4180995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
    Lazarus JH; Marchant B; Alexander WD; Clark DH
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Side-effects of synthetic antithyroid drugs].
    Ducornet B; Duprey J
    Ann Med Interne (Paris); 1988; 139(6):410-31. PubMed ID: 2464962
    [No Abstract]   [Full Text] [Related]  

  • 12. Biliary excretion of 35 S-labelled propylthiouracil, methimazole and carbimazole in untreated and pentobarbitone pretreated rats.
    Papapetrou PD; Marchant B; Gavras H; Alexander WD
    Biochem Pharmacol; 1972 Feb; 21(3):363-77. PubMed ID: 4111354
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
    Shiroozu A; Taurog A; Engler H; Dorris ML
    Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action.
    Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of iodide derived from intrathyroidal hyrolysis of thyroglobulin.
    Greer MA; Grimm Y; Inoue K
    Endocrinology; 1969 Nov; 85(5):837-45. PubMed ID: 4185335
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of inactivation of thyroid peroxidase by thioureylene drugs.
    Engler H; Taurog A; Nakashima T
    Biochem Pharmacol; 1982 Dec; 31(23):3801-6. PubMed ID: 6186257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole.
    Ferreira AC; de Carvalho Cardoso L; Rosenthal D; de Carvalho DP
    Eur J Biochem; 2003 Jun; 270(11):2363-8. PubMed ID: 12755690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
    Lees JF; Alexander WD
    Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.
    Melander A; Hallengren B; Rosendal-Helgesen S; Sjöberg AK; Wählin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):295-9. PubMed ID: 6156842
    [No Abstract]   [Full Text] [Related]  

  • 20. The placental transfer of propylthiouracil, methimazole and carbimazole.
    Marchant B; Brownlie BE; Hart DM; Horton PW; Alexander WD
    J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.